Early Pro-inflammatory Cytokine Elevations in the DBA/2J Mouse Model of Glaucoma
Overview
Authors
Affiliations
Background: Neuroinflammation-astrogliosis, microglial activation, and changes in cytokine signaling-is a prominent feature of neurodegenerative disorders. Glaucoma is a group of chronic neurodegenerative conditions that make up the leading cause of irreversible blindness worldwide. Neuroinflammation has been postulated to play a significant role in the pathogenesis and progression of glaucomatous neurodegeneration. Though much is known regarding inflammation in the eye in glaucoma, little is known about cytokine activity outside of the retina where pathologies develop early.
Methods: We traced the primary visual projection from the eye to the superior colliculus (SC) in DBA/2J and DBA/2J.Gpnmb (+) (control) mice using the anterograde tracer cholera toxin-B (CTB) to assay axonal transport deficits. Forty-eight hours later, visual structures were microdissected from fresh tissue based on transport outcome. Using magnetic bead multiplexing assays, we measured levels of 20 cytokines in the retina, proximal and distal optic nerves, CTB-positive and negative SC subdivisions, cerebellum, and serum at different ages representing different stages of pathology.
Results: Pro- and anti-inflammatory cytokine levels in mice often changed in the same direction based on strain, age, and tissue. Significant elevations in retinal pro-inflammatory cytokines were observed in young DBA/2J mice compared to controls, followed by an age-dependent decrease in the DBA/2J mice. Proximal optic nerve of young DBA/2J mice showed a 50 % or greater decrease in levels of certain cytokines compared to older DBA/2J cohorts and controls, while both proximal and distal optic nerve of DBA/2Js showed elevations in IL-1β at all ages compared to controls. Pro-inflammatory cytokine IL-6 levels varied in accordance with transport outcome in the SC: IL-6 was elevated 44-80 % in glaucomatous DBA/2J collicular regions deficient in anterograde transport from retinal ganglion cells (RGCs) compared to areas with intact transport.
Conclusion: Dysregulation of cytokine signaling in the RGC projection of DBA/2J mice was evident early in distal retinal targets, well before intraocular pressure elevation or axonal degeneration begins.
Fibrosis and Src Signalling in Glaucoma: From Molecular Pathways to Therapeutic Prospects.
Bourke L, OBrien C Int J Mol Sci. 2025; 26(3).
PMID: 39940776 PMC: 11817269. DOI: 10.3390/ijms26031009.
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.
Millington-Ward S, Palfi A, Shortall C, Finnegan L, Bargroff E, Post I Int J Mol Sci. 2024; 25(16).
PMID: 39201561 PMC: 11354491. DOI: 10.3390/ijms25168876.
Langbol M, Saruhanian A, Saruhanian S, Tiedemann D, Baskaran T, Vohra R Cell Mol Neurobiol. 2024; 44(1):59.
PMID: 39150567 PMC: 11329415. DOI: 10.1007/s10571-024-01492-3.
Association of plasma lactoferrin levels with disease severity in glaucoma patients.
Wang Z, Liu D, Yuan H, Li A, Wang J, Zhu X Front Med (Lausanne). 2024; 11:1385358.
PMID: 38873213 PMC: 11169593. DOI: 10.3389/fmed.2024.1385358.
Molecular pathways in experimental glaucoma models.
Bugara K, Pacwa A, Smedowski A Front Neurosci. 2024; 18:1363170.
PMID: 38562304 PMC: 10982327. DOI: 10.3389/fnins.2024.1363170.